Blocked polyisocyanate

Abstract

The invention relates to a blocked polyiosocyanate, which contains two or more 2-carbamoylpropane-1,2,3-tricarboxylate structures, and to a process of production thereof. The invention further relates to a composition containing the blocked polyisocyanate, but also to moldings or coated substrates made of the blocked polyisocyanates.

Description

[0001] Blocked polyisocyanate

[0002] The present invention relates to a blocked polyisocyanate and a process for its preparation. Furthermore, the invention relates to the use of citrates, a composition containing the blocked polyisocyanate, and also molded articles or coated substrates made from the blocked polyisocyanates.

[0003] The use of blocking agents to temporarily deactivate isocyanate groups has long been known. Blocked polyisocyanates are used, among other things, to produce 1-component polyurethane systems that are stable at room temperature and begin to crosslink when the blocking agent's deblocking temperature is reached. The blocked polyisocyanates are reacted with typical isocyanate-reactive compounds, such as hydroxyl-containing polyesters or polyacrylates. 1-component polyurethane coatings are used today in can & coil coating, automotive OEM finishing, and plastics coating. Depending on the requirements, various polyisocyanates based on aliphatic diisocyanates are used.Examples include the linear aliphatic diisocyanates hexamethylene diisocyanate (HDI) and pentamethylene diisocyanate (PDI) or the cycloaliphatic diisocyanates isophorone diisocyanate (PDI) and 4,4'-diisocyanatodicyclohexylmethane (“H12MDI”).

[0004] Review articles on the use of blocked polyisocyanates and their properties can be found, for example, in Wicks, Z. Progress in Organic Coatings 3 (1975) 73-99, Wicks, Z. Progress in Organic Coatings 9 (1981) 3-28 , DA Wicks and ZW Wicks, Progress in Organic Coatings, (1999), 148-172.

[0005] US 2016 / 090438 A1 discloses the use of a citrate for hydrophobizing a polyurethane used for coating textiles, but not a blocking of a polyisocyanate within the meaning of this invention.

[0006] EP 0 669 355 A1 discloses a solvent-free and continuous process for the preparation of totally or partially blocked polyisocyanates, but without disclosing the presence of 2-carbamoylpropane-1,2,3-tricarboxylate structures.

[0007] The blocking agent has a significant influence on the properties of 1-component polyurethane systems. For example, the blocking agent significantly influences the reactivity (deblocking temperature), thermal yellowing, compatibility, and viscosity of the 1-component polyurethane formulation. (U. Meier-Westhues et al. "Polyurethanes: Coatings, Adhesives and Sealants", 2nd Revised Edition, pp. 35-42, Hanover: Vincentz Network, 2019).

[0008] The technically most relevant blocking agents are e-caprolactam, methyl ethyl ketoxime (hereinafter also called butanone oxime or MEKO), diethyl malonate, secondary amines and triazole and pyrazole derivatives, described for example in EP-A 0 576 952, EP-A 0 566 953, EP-A 0 159 117, US-A 4482 721, WO 97 / 12924 or EP-A 0 744423.

[0009] Polyisocyanates blocked with aliphatic alcohols such as methanol or ethanol are generally not used as blocking agents due to very high baking temperatures (>180°C). Polyisocyanates blocked with aromatic alcohols, such as phenol, have lower baking temperatures than their aliphatic counterparts (approximately 150°C for phenol), but are not widely used due to disadvantages related to compatibility, solubility, and toxicity.

[0010] The most commonly used blocking agents for isocyanates are e-caprolactam and MEKO. While e-caprolactam typically requires baking temperatures of 170°C or higher, blocked 1-component polyurethane baking coatings containing MEKO can be baked at temperatures 10 to 20°C lower. However, MEKO is disadvantageous due to its toxicological properties.

[0011] Blocked polyisocyanates based on linear aliphatic diisocyanates such as HDI and PDI have a strong tendency toward crystallization and solidification, but due to their property profile, they are indispensable for high-quality polyurethane stoving coatings. Polyisocyanates based on linear aliphatic diisocyanates blocked with e-caprolactam or MEKO (due to their asymmetric structures) exhibit a lower tendency toward crystallization and solidification compared to other blocking agents, but exhibit disadvantages with regard to processable viscosities, especially in high-solids formulations.

[0012] Furthermore, many blocking agents are based entirely on fossil raw materials, which is another disadvantage of the blocking agents known in the state of the art.

[0013] The present invention was therefore based on the object of providing blocked polyisocyanates which do not have the aforementioned disadvantages of the prior art and have a significantly lower viscosity of the blocked polyisocyanates with a considerably lower toxicity of the blocking agent.

[0014] This problem could be solved by providing a blocked polyisocyanate containing two or more 2-carbamoylpropane-1,2,3-tricarboxylate structures.

[0015] Surprisingly, it was discovered that triesters of citric acid (also referred to as "citrates" in the context of the invention) can be used as blocking agents for isocyanates. Furthermore, it is surprising that triesters of citric acid, as tertiary alcohols, are even suitable as blocking agents for isocyanates, since urethane adducts of tertiary alcohols and isocyanates generally tend to undergo elimination reactions upon heating. The latter is used industrially, for example, to produce polyisocyanates with a biuret structure using the tert-butanol process, as described, for example, in DE1931055 or DE1543578.

[0016] The terms "comprising" or "containing" preferably mean "consisting essentially of," and particularly preferably "consisting of." The further embodiments mentioned in the claims and in the description can be combined in any way, unless the context clearly indicates otherwise.

[0017] "At least one," as used herein, refers to 1 or more, for example, 2, 3, 4, 5, 6, 7, 8, 9, or more. In the context of components of the compounds described herein, this statement does not refer to the absolute amount of molecules, but rather to the type of component. "At least one polyisocyanate component" therefore means, for example, that only one type of polyisocyanate component or several different types of polyisocyanate components may be present, without specifying the amount of the individual components.

[0018] Numerical values ​​stated without decimal places refer to the full specified value with one decimal place. For example, "99%" stands for "99.0%."

[0019] Numerical ranges specified in the format "in / from x to y" include the specified values. If multiple preferred numerical ranges are specified in this format, it is understood that all ranges resulting from the combination of the different endpoints are also included.

[0020] For the purposes of this document, the term "aliphatic" is defined as non-aromatic hydrocarbon groups that are branched or unbranched and saturated or unsaturated.

[0021] As used herein, the term "alicyclic" or "cycloaliphatic" is defined as optionally substituted, carbocyclic, or heterocyclic compounds or moieties that are not aromatic (such as cycloalkanes, cycloalkenes, or oxa-, thia-, aza-, or thiazacycloalkanes). Specific examples include cyclohexyl groups, cyclopentyl groups, and their N- or O-heterocyclic derivatives, such as pyrimidine, pyrazine, tetrahydropyran, or tetrahydrofuran.

[0022] Here, the term "araliphatic" is defined as aliphatic hydrocarbon radicals that are saturated or unsaturated and have at least one aromatic substituent.

[0023] In the event that the groups or compounds are disclosed as "optionally substituted" or "substituted," suitable substituents are -F, -Cl, -Br, -I, -OH, -OCH3, OCH2CH3, -O-isopropyl or -on-propyl, -OCF3, -CF3, -S-C1-6alkyl, and / or (optionally via an attached heteroatom) a linear or branched, aliphatic and / or alicyclic structural unit having 1 to 12 carbon atoms, each acting as a replacement for a carbon-bonded hydrogen atom of the molecule in question. Preferred substituents are halogen (especially -F, -Cl), C1-6alkoxy (especially methoxy and ethoxy), hydroxy, trifluoromethyl, and trifluoromethoxy, each acting as a replacement for a carbon-bonded hydrogen atom of the molecule in question.

[0024] Polyisocyanates A) for the blocked polyisocyanate according to the invention and the process according to the invention are any diisocyanates, triisocyanates and / or polyisocyanates with aliphatically, cycloaliphatically, araliphatically and / or aromatically bound isocyanate groups.

[0025] Suitable diisocyanates and triisocyanates A) are any diisocyanates and triisocyanates which can be obtained in various ways, for example by phosgenation of the corresponding diamines or triamines, which can be produced using fossil raw materials or else from renewable raw materials, optionally with a mass balance, in the liquid or gas phase or by a phosgene-free route, such as by thermal urethane cleavage, preferably those in the molecular weight range 140 to 400 with aliphatically, cycloaliphatically, araliphatically and / or aromatically bound isocyanate groups, such as, for example, B. 1,4-diisocyanatobutane, 1,5-diisocyanatopentane (PDI), 1,6-diisocyanatohexane (HDI), 2-methyl-1,5-diisocyanatopentane, 1,5-diisocyanato-2,2-dimethylpentane, 2,2,4- or 2,4,4-trimethyl-1,6-diisocyanatohexane, 1,8-diisocyanatooctane, 1,9-diisocyanatononane, 1,10-diisocyanatodecane, 1,3- and 1,4-diisocyanatocyclohexane, 1,3- and 1,4-bis-(isocyanatomethyl)-cyclohexane,1-lsocyanato-3,3,5-trimethyl-5- isocyanatomethylcyclohexan (Isophorondiisocyanat, IPDI), 2,4’- und 4,4'-Diiso- cyanatodicyclohexylmethan (H12-MDI), 4,4'-Diisocyanato-3,3'-dimethyldicyclohexylmethan, 4,4'-Diisocyanato-3,3',5,5'-tetramethyldicyclohexylmethan, 4,4'-Diisocyanato-1 ,T- bi(cyclohexyl), 4,4'-Diisocyanato-3,3'-dimethyl-1 ,1'-bi(cyclohexyl), 4,4'-Diisocyanato-2,2',5,5'- tetra-methyl-1 ,1'-bi(cyclohexyl), 1 ,8-Diisocyanato-p-menthan, 1 ,3-Diisocyanatoadamantan, 1 ,3-Dimethyl-5,7-diisocyanatoadamantan, 1-lsocyanato-1-methyl-4(3)isocyanato- methylcyclohexan, Bis-(isocyanatomethyl)-norbornan (NBDI), 4-lsocyanatomethyl-1 ,8- octandiisocyanat (Triisocyanatononan; TIN), 1 ,3- und 1 ,4-Bis(isocyanatomethyl)benzol (Xylylendiisocyanat, XDI), 1 ,3- und 1 ,4-Bis-(2-isocyanato-prop-2-yl)-benzol (TMXDI), 1 ,3- Bis(isocyanatomethyl)-4-methylbenzol, 1 ,3-Bis(isocyanatomethyl)-4-ethylbenzol, 1 ,3- Bis(isocyanatomethyl)-5-methylbenzol, 1 ,3-Bis(isocyanatomethyl)-4,5-dimethylbenzol, 1 ,4-bis(isocyanatomethyl)-2,5-dimethylbenzene, 1,4-bis(isocyanatomethyl)-2,3,5,6-tetramethylbenzene, 1,3-bis(isocyanatomethyl)-5-tert-butylbenzene, 1,3-bis(isocyanatomethyl)-4-chlorobenzene, 1,3-bis(isocyanatomethyl)-4,5-dichlorobenzene, 1,3-bis(isocyanatomethyl)-2,4,5,6-tetrachlorobenzene, 1,4-bis(isocyanatomethyl)-2,3,5,6-tetrachlorobenzene, 1,4-bis(isocyanatomethyl)-2,3,5,6-tetrabromobenzene, 1,4-bis(2-isocyanatoethyl)benzene and 1,4-bis(isocyanatomethyl)naphthalene, 1,2-, 1 ,3- and 1 ,4-diisocyanatobenzene,

[0026] (phenylene diisocyanate), 2,4- and 2,6-diisocyanatotoluene (TDI), 2,3,5,6-tetramethyl-1,4-diisocyanatobenzene, the isomeric diethylphenylene diisocyanates,

[0027] Diisopropylphenylene diisocyanates, diisododecylphenylene diisocyanates and

[0028] Biphenyl diisocyanates, 3,3'-dimethoxybiphenyl-4,4'-diisocyanate, 2,2'-, 2,4'- and 4,4'-diisocyanatodiphenylmethane (MDI), 3,3'-dimethyldiphenylmethane-4,4'-diisocyanate, 4,4'-diisocyanatodiphenylethane, 1 ,5-Diisocyanatonaphthalene (naphthylene diisocyanate, NDI), diphenyl ether diisocyanate, ethylene glycol diphenyl ether diisocyanate,

[0029] Diethylene glycol diphenyl ether diisocyanate, 1,3-propylene glycol diphenyl ether diisocyanate, benzophenone diisocyanate, triisocyanatobenzene, 2,4,6-triisocyanatotoluene,

[0030] Trimethylbenzene triisocyanate, diphenylmethane-2,4,4'-triisocyanate, 3-methyldiphenylmethane-4,6,4'-triisocyanate, the isomeric naphthalene triisocyanates and methylnaphthalene diisocyanates, triphenylmethane triisocyanate, 2,4-diisocyanato-1-[(5-isocyanato-2-methylphenyl)methyl]benzene or mixtures of at least two such diisocyanates and triisocyanates.

[0031] Suitable polyisocyanates A) are any polyisocyanates having a uretdione, isocyanurate, allophanate, biuret, iminooxadiazinedione and / or oxadiazinetrione structure prepared by modifying simple aliphatic, cycloaliphatic, araliphatic and / or aromatic diisocyanates and / or triisocyanates, for example those of the type mentioned above, as described, for example, in J. Prakt. Chem. 336 (1994) 185 - 200, in DE-A 1 670 666, DE-A 1 954 093, DE-A 2 414 413, DE-A 2 452 532, DE-A 2 641 380, DE-A 3 700 209, DE-A 3 900 053 and DE-A 3 928 503 or in EP-A 0 336 205, EP-A 0 339 396 EP-A 0 798299, EP-A 0 962 454, EP-A 0 962 455, EP-A 2 785760, EP-A 2 883 895, EP-A 3 107922, EP-A 3 107 948 and EP-A 3 337 836 or any mixtures of such polyisocyanates.

[0032] If necessary, when modifying the above-mentioned diisocyanates and / or triisocyanates to polyisocyanates A), minor amounts of monoisocyanates, in particular those in the molecular weight range 99 to 300, such as n-butyl isocyanate, n-amyl isocyanate, n-hexyl isocyanate, n-heptyl isocyanate, n-octyl isocyanate, undecyl isocyanate, dodecyl isocyanate, tetradecyl isocyanate, cetyl isocyanate, stearyl isocyanate,

[0033] Cyclopentyl isocyanate, cyclohexyl isocyanate, 3- or 4-methylcyclohexyl isocyanate, benzyl isocyanate, phenyl isocyanate or naphthyl isocyanate may also be used. If at all, monoisocyanates are used in amounts of up to 30 wt. %, preferably up to 20 wt. %, particularly preferably up to 10 wt. %, based on the total amount of mono-, di- and triisocyanates. In the preparation of the polyisocyanates A), the actual modification reaction is generally followed by a further process step for separating off the unreacted excess monomeric diisocyanates and / or triisocyanates and, if appropriate, monoisocyanates. This monomer separation is carried out by processes known per se, preferably by thin-film distillation under reduced pressure or by extraction with suitable solvents that are inert towards isocyanate groups, for example aliphatic or cycloaliphatic hydrocarbons such as pentane, hexane, heptane, cyclopentane or cyclohexane.

[0034] In a first preferred embodiment of the invention, the blocked polyisocyanate is characterized in that it additionally contains one or more isocyanurate, allophanate, urethane, urea, uretdione, iminooxadiazinedione, oxadiazinetrione and / or biuret structures.

[0035] Preferably, in the process according to the invention or as starting material in the blocked polyisocyanate according to the invention, polyisocyanates of the type mentioned are used as polyisocyanate A) which have an isocyanate group content of 6.0 to 26.0 wt.%, preferably 8.0 to 25.0 wt.%, particularly preferably 10.0 to 24.0 wt.%, and / or a monomeric diisocyanate content of less than 0.50 wt.%, preferably less than 0.30 wt.%, more preferably less than 0.20 wt.%, particularly preferably less than 0.10 wt.%. For the alternative, optional case that triisocyanates and / or monoisocyanates were used to prepare the polyisocyanates A), the above-mentioned residual monomer contents of less than 0.50 wt.%, preferably less than 0.30 wt.%, more preferably less than 0.20 wt.%, particularly preferably less than 0.10 wt.% refer to all diisocyanates, triisocyanates and monoisocyanates used.The NCO contents are determined according to DIN EN ISO 11909:2007-05, the residual monomer contents according to DIN EN ISO 10283:2007-11 using gas chromatography with an internal standard.

[0036] Particularly preferred polyisocyanates A) are those of the type mentioned with exclusively aliphatically and / or cycloaliphatically bound isocyanate groups.

[0037] Very particularly preferred polyisocyanates A) are polyisocyanates containing at least isocyanurate structures and based on 1,5-diisocyanatopentane, 1,6-diisocyanatohexane, 1-isocyanato-3,3,5-trimethyl-5-isocyanatomethylcyclohexane, 1,3-bis(isocyanatomethyl)benzene, bis(isocyanatomethyl)norbornane and / or 4,4'-diisocyanatodicyclohexylmethane.

[0038] In a further preferred embodiment, the free NCO content of the blocked polyisocyanate according to the invention is 5 wt.%, preferably 2 wt.%, particularly preferably 1 wt.%, even more preferably 0.5 wt.% and very particularly preferably 0.3 wt.%, determined by titration according to DIN EN ISO 11909:2007-05 and based on the total weight of the blocked polyisocyanate.

[0039] The blocked polyisocyanates according to the invention can be identified, for example, by NMR spectrometry or HPLC-MS by qualitative and quantitative determination of the 2-carbamoylpropane-1,2,3-tricarboxylate structures.

[0040] In a further preferred embodiment, the two or more 2-carbamoylpropane-1,2,3-tricarboxylate structures of the blocked polyisocyanate according to the invention have a general formula (I), (I) in which

[0041] R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 18 carbon atoms, saturated or unsaturated cycloaliphatic radical having 3 to 18 carbon atoms, araliphatic radical having 7 to 18 carbon atoms and / or aromatic radical having 6 to 18 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain.

[0042] In a likewise preferred embodiment, the two or more 2-carbamoylpropane-1,2,3-tricarboxylate structures of the blocked polyisocyanate according to the invention have a general formula (I), (I) in which

[0043] R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 8 carbon atoms and / or saturated or unsaturated cycloaliphatic radical having 5 to 8 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain, preferably in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 4 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain, particularly preferably in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 2 to 4 carbon atoms.

[0044] The carbamoylpropane-1,2,3-tricarboxylate structures, and thus also the structures of general formula (I), represent the blocked NCO groups, with a corresponding citrate acting as a blocking agent. Since blocking agents are always used in large quantities to block essentially all free isocyanate groups, citrates offer the ecological advantage of being accessible on an industrial scale from (partially) bio-based raw materials.

[0045] The present invention further provides a process for preparing a blocked polyisocyanate, comprising reacting at least one polyisocyanate A) with at least one citrate B), optionally in the presence of at least one catalyst, wherein the citrate B) is used in an amount of > 95 equivalent% based on the isocyanate groups of the polyisocyanate A).

[0046] The suitable and preferred polyisocyanates A) are those described above. In a further preferred embodiment of the process according to the invention, the at least one polyisocyanate A) has aliphatically, cycloaliphatically, araliphatically and / or aromatically bound isocyanate groups and / or preferably comprises one or more polyisocyanates containing isocyanurate structures based on 1,5-diisocyanatopentane, 1,6-diisocyanatohexane, 1-isocyanato-3,3,5-trimethyl-5-isocyanatomethylcyclohexane, 1,3-bis(isocyanatomethyl)benzene, bis(isocyanatomethyl)norbornane and / or 4,4'-diisocyanatodicyclohexylmethane.

[0047] The citrate B) is preferably used in an amount of 3 = 98 equivalent%, particularly preferably > 99 equivalent%, even more preferably > 99.5 equivalent% and most preferably > 99.7 equivalent%, based on the isocyanate groups of the polyisocyanate A).

[0048] The at least one citrate B) can be selected from various compounds. In a further preferred embodiment of the process according to the invention, the at least one citrate B) is one of the general formula (II),

[0049] (II), in which

[0050] R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 18 carbon atoms, saturated or unsaturated cycloaliphatic radical having 3 to 18 carbon atoms, araliphatic radical having 7 to 18 carbon atoms and / or aromatic radical having 6 to 18 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain.

[0051] In a further preferred embodiment of the process according to the invention, the at least one citrate B) is one of the general formula (II),

[0052] (II), in which

[0053] R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 8 carbon atoms and / or saturated or unsaturated cycloaliphatic radical having 5 to 8 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain, preferably in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 4 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain, particularly preferably in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 2 to 4 carbon atoms.

[0054] Beispielhafte geeignete und bevorzugte Citrate B) sind Tri methyl citrat, Triethylcitrat, Tri-n- propylcitrat, Tri-iso-propylcitrat, Tri-n-butylcitrat, Tri-sec-butylcitrat, Tri-iso-butylcitrat, Tri-tert- butylcitrat, Tri-n-pentylcitrat, Tri(2-pentyl)citrat, Tri(3-pentyl)citrat, Tri(2-methyl-1-butyl)citrat , T ri (2-methy l-2-buty l)citrat, T ri-(3-methyl-1 -buty l)citrat, T ri (3-methy l-2-buty l)citrat, T ri (2 , 2- Dimethyl-1-propyl)citrat, Tri-n-hexylcitrat, Tri(2-hexyl)citrat, Tri(3-hexyl)citrat, Tri(2-methyl-1- pentyl)citrat, Tri(2-methyl-2-pentyl)citrat, Tri(2-methyl-3-pentyl)citrat, Tri(4-methyl-1- pentyl)citrat, Tri(4-methyl-2-pentyl)citrat, Tri(3-methyl-1-pentyl)citrat, Tri(3-methyl-2- pentyl)citrat, Tri(3-methyl-3-pentyl)citrat, Tri(2,2-dimethyl-1 -butyl)citrat, Tri(3,3-dimethyl-1- buty l)citrat, T ri (3, 3-d imethy l-2-buty l)citrat, T ri(2,3-dimethyl-1 -buty l)citrat, T ri(2,3-dimethyl-2- butyl)citrat, Tri(2-ethyl-1-butyl)citrat, Tri-n-heptylcitrat, Tri-(2-heptyl)citrat,Tri-(3-heptyl)citrat, T ri-(4-heptyl)citrat, T ri(5-methyl-1 -hexyl)citrat, T ri(5-methyl-2-hexyl)citrat, T ri(5-methyl-3- hexyl)citrat, T ri(2-methyl-3-hexyl)citrat, T ri(2-methyl-2-hexyl)citrat, T ri(2-methyl-1 -hexyl)citrat, Tri(4-methyl-1-hexyl)citrat, Tri(4-methyl-2-hexyl)citrat, Tri(4-methyl-3-hexyl)citrat, Tri(3- methyl-3-hexyl)citrat, Tri(3-methyl-2-hexyl)citrat, Tri(3-methyl-1-hexyl)citrat, Tri(2-ethyl-1 - penty l)citrat, T ri (3-ethy I- 1 -penty l)citrat, T ri (3-ethy l-2-penty l)citrat, T ri (3-ethy l-3-penty l)citrat, Tri(3,4-dimethyl-1 -pentyl)citrat, Tri(3,4-dimethyl-2-pentyl)citrat, Tri(2,3-dimethyl-1 -pentyl)citrat, Tri(2,3-dimethyl-2-pentyl)citrat,Tri(2,3-dimethyl-3-pentyl)citrat, Tri(2-isopropyl-1-butyl)citrat, Tri(2,3,3-trimethyl-1-butyl)citrat); Tri(2,2,3-trimethyl-1 -butyl)citrat); Tri(2,3,3-trimethyl-2- buty l)ci trat) , T ri (3 , 3-d i methyl- 1 -penty l)citrat, T ri(3,3-dimethyl-2-pentyl)citrat, T ri (2-ethy I-,

[0055] 2methyl-1-butyl)citrat, Tri(4,4-dimethyl-1-pentyl)citrat, Tri(4,4-dimethyl-2-pentyl)citrat, Tri(2,2- dimethyl-1-pentyl)citrat, Tri-n-octylcitrat, Tri (2-octy I) citrat, Tri(3-octyl)citrat), Tri (4-octy I) citrat,

[0056] T ri(2-methyl-1 -hepty l)citrat, T ri(2-methyl-2-heptyl)citrat, T ri(2-methyl-3-heptyl)citrat, T ri (2- methyl-4-heptyl)citrat, T ri(3-methyl-1 -hepty l)citrat, T ri(3-methyl-2-heptyl)citrat, T ri(3-methyl-3- hepty l)citrat, T ri(3-methyl-4-heptyl)citrat, T ri(4-methyl-1 - hepty I) citrat, , Tri(4-methyl-3- hepty l)citrat, T ri(4-methyl-4-heptyl)citrat, Tri(5-methyl-1-heptyl)citrat, Tri(5-methyl-2- hepty l)citrat, T ri(5-methyl-3-heptyl)citrat, Tri(6-methyl-1-heptyl)citrat, Tri(6-methyl-2- hepty l)citrat, T ri(6-methyl-3-heptyl)citrat, T ri (2 , 2-d i methyl- 1 -hexyl)citrat, T ri(2,2-dimethyl-3- hexyl)citrat, Tri(2,3-dimethyl-1-hexyl)citrat , Tri(2,3-dimethyl-2-hexyl)citrat, Tri(2,3-dimethyl-3- hexyl)citrat, T ri (2 , 4-d i methy I- 1 -hexyl)citrat, T ri(2,4-dimethyl-2-hexyl)citrat, T ri(2,4-dimethyl-3- hexyl)citrat T ri (2 , 5-d i methy I- 1 -hexyl)citrat, T ri(2,5-dimethyl-2-hexyl)citrat, T ri(2,5-dimethyl-3- hexyl)citrat, Tri(3,3-dimethyl-1-hexyl)citrat, Tri(3,3-dimethyl-2-hexyl)citrat, Tri(3,4-dimethyl-1- hexyl)citrat, T ri(3,4-dimethyl-2-hexyl)citrat, T ri(3,4-dimethyl-3-hexyl)citrat, T ri (3, 5-di m ethy I- 1 - hexyl)citrat, T ri(3,5-dimethyl-2-hexyl)citrat,T ri(3,5-dimethyl-3-hexyl)citrat, T ri (4, 4-d i methyl- 1 - hexyl)citrat, T ri(4,4-dimethyl-2-hexyl)citrat, T ri(4,4-dimethyl-3-hexyl)citrat, T ri (4, 5-di m ethy I- 1 - hexyl)citrat, T ri(4,5-dimethyl-2-hexyl)citrat, T ri(4,5-dimethyl-3-hexyl)citrat, T ri (5, 5-di m ethy I- 1 - hexyl)citrat, Tri(5,5-dimethyl-2-hexyl)citrat, Tri(5,5-dimethyl-3-hexyl)citrat, Tri(2-ethyl-1 - hexyl)citrat, Tri(3-ethyl-1-hexyl)citrat, Tri(3-ethyl-2-hexyl)citrat, Tri(3-ethyl-3-hexyl)citrat, Tri(4- ethyl-1-hexyl)citrat, Tri(4-ethyl-2-hexyl)citrat, Tri(4-ethyl-3-hexyl)citrat, Tri(2-propyl-1 - pentyl)citrat, Tri(2-ethyl-2-methyl-1-pentyl)citrat, Tri(2-ethyl-3-methyl-1-pentyl)citrat, Tri(2- ethyl-4-methyl-1-pentyl)citrat, Tri(3-ethyl-2-methyl-1-pentyl)citrat, Tri(3-ethyl-2-methyl-2- pentyl)citrat,Tri(3-ethyl-2-methyl-3-pentyl)citrat, , Tri(3-ethyl-3-methyl-1-pentyl)citrat, , Tri(3- ethyl-3-methyl-2-pentyl)citrat, Tri(3-ethyl-4-methyl-1-pentyl)citrat, Tri(3-ethyl-4-methyl-2- penty l)citrat, T ri (2 , 2 , 3-tri methy I- 1 -pentyl)citrat), T ri (2 , 2 , 3-tri methy l-2-penty I) citrat) , T ri (2 , 2 , 3- trimethyl-3-pentyl)citrat) , Tri(2,2,4-trimethyl-1-pentyl)citrat), Tri(2,2,4-trimethyl-3-pentyl)citrat), Tri(2,3,3-trimethyl-1-pentyl)citrat), Tri(2,3,3-trimethyl-2-pentyl)citrat), Tri(2,3,4-trimethyl-1 - penty l)citrat) , T ri (2 , 3, 4-tri methy l-2-penty l)citrat) , T ri (2 , 3, 4-tri methy l-3-penty I) ci trat) , T ri (2 , 4, 4- trimethyl-1 -pentyl)citrat), Tri(2,4,4-trimethyl-2-pentyl)citrat), Tri(3,3,4-trimethyl-1-pentyl)citrat), T ri (3 , 3, 4-tri methy l-2-penty l)citrat) , T ri (3, 4, 4-tri methy I- 1 -pentyl) citrat), T ri (3, 4, 4-tri methy I-2- pentyl)citrat),Tri(2-Ethyl-2,3-dimethyl-1 -butyl)citrat, Tri(2-Ethyl-3,3-dimethyl-1 -butyl)citrat,Tri(3-methyl-2-(1-methylethyl)-1-butyl) citrate, Tri(2,2-diethyl-1 -butyl) citrate, Tri(2, 2,3,3- Tetramethyl-1 -butyl Qcitrate, Trivinyl citrate, Trial ly citrate, Tri(2-(acryloyloxy)ethyl) citrate, Tri(2- (Methacryloyloxy)ethyl) citrate, tribenzyl citrate, triphenyl citrate, tricyclopropyl citrate, tricyclobutyl citrate, tricyclopentyl citrate, tricyclohexyl citrate, tricycloheptyl citrate, tricyclooctyl citrate and mixtures of the aforementioned. Particularly preferred citrates B) are trimethyl citrate, triethyl citrate, tripropyl citrate, triisopropyl citrate, tri-n-butyl citrate, Tri-sec-butyl citrate, tri-iso-butyl citrate, tri-tert-butyl citrate, tri- n-pentyl citrate, tri-n-hexyl citrate, tri-n-octyl citrate, tri(2-ethyl-1-hexyl) citrate and mixtures of the above, and very particularly preferred citrates B) are trimethyl citrate, triethyl citrate, tributyl citrate and mixtures of the above.

[0057] If desired, the citrates B) mentioned can also be mixed esterified, for example diethyl methyl citrate or butyl diethyl citrate.

[0058] Since the citrates B) form the 2-carbamoylpropane-1,2,3-tricarboxylate structures of the blocked polyisocyanates according to the invention with the isocyanate groups, the 2-carbamoylpropane-1,2,3-trimethoxylate structures, 2-carbamoylpropane-1,2,3-triethoxylate structures, 2-carbamoylpropane-1,2,3-tributoxylate structures and mixtures of the abovementioned are very particularly preferred structures and very particularly preferred embodiments of the general formula (I).

[0059] In contrast to the blocking agents known from the state of the art, citric acid esters such as triethyl citrate are not toxic, irritating or otherwise harmful to health.

[0060] To carry out the process according to the invention, the at least one polyisocyanate A) is reacted with the at least one citrate B) preferably at temperatures of 20 to 120 °C, particularly preferably 40 to 100 °C, to form the blocked polyisocyanate according to the invention.

[0061] The blocking reaction in the process according to the invention can be carried out thermally induced without a catalyst or in the presence of at least one catalyst. Preferably, the reaction is carried out in the presence of at least one catalyst. This has the advantage of further increasing the efficiency and economic viability of the process.

[0062] Suitable catalysts are tertiary amines such as triethylamine, pyridine, methylpyridine, 1,4-diazabicyclo[2.2.2]octane, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,5-diazabicyclo[4.3.0]non-5-ene, 4-(dimethylamino)pyridine, benzyldimethylamine, N,N-endoethylenepiperazine, N-methylpiperidine, pentamethyldiethylenetriamine, N,N-dimethylaminocyclohexane, N,N'-dimethylpiperazine, but also metal salts and chelates, salts of transition metals, semimetals or inorganic bases such as potassium carbonate. The metal ions preferably used as catalytically active metal ions are iron(III), bismuth(III), zinc(II), tin(II), tin(IV), zirconium(IV), titanium(IV), molybdenum(VI) and Al(III).Examples include iron(III) chloride, bismuth(III) octoate, bismuth(III) triflate, bismuth(III) neodecanoate, aluminum tri(ethyl acetoacetate), zinc(II) chloride, zinc(II) n-octanoate, zinc(II)-2-ethyl-1-hexanoate, zinc 2-ethyl caproate, zinc(II) stearate, Zinc(II) naphtenate, zinc(II) acetylacetonate, tin(II) n-octanoate, tin(II)-2-ethyl-1-hexanoate, tin(II) ethyl caproate, tin(II) laurate, tin(II) palmitate), tin(II) triflate, tin(II) chloride, dibutyltin(IV) oxide, Dibutyltin(IV) dichloride, dibutyltin(IV) diacetate, Dibutyltin(IV) dimaleate, dibutyltin(IV) dilaurate, dioctyltin(IV) diacetate, molybdenum glycolate, tetraisopropyl titanate, tetrabutylitanate, titanium(IV) acetylacetonate, zirconium(IV) neodecanoate, aluminum tri-sec-butylate, aluminum(III) acetylacetonate, aluminum(III) triflate or any mixtures of such catalysts may be used.

[0063] The at least one catalyst which may be present in the process according to the invention is preferably present in amounts of from 1 to 10,000 ppm, preferably from 10 to 5,000 ppm, particularly preferably from 10 to 1,000 ppm and very particularly preferably from 10 to 250 ppm.

[0064] A further advantage of the aforementioned metal ion-containing catalysts is that they can be measured qualitatively and quantitatively in the blocked polyisocyanates according to the invention, for example by means of ICP-OES or ICP-MS.

[0065] The process according to the invention can be carried out solvent-free. However, suitable solvents that are inert toward the reactive groups of the polyisocyanates A) can also be used if desired. Suitable solvents for this purpose include those produced using fossil raw materials or renewable raw materials, in particular the conventional paint solvents known per se, such as, for example,Ethyl acetate, butyl acetate, ethylene glycol monomethyl or ethyl ether acetate, 1-methoxypropyl-2-acetate, 3-methoxy-n-butyl acetate, ethyl (-)-L-lactate, acetone, 2-butanone, 4-methyl-2-pentanone, cyclohexanone, dihydrolevoglucosenone, toluene, xylene, chlorobenzene, white spirit, higher substituted aromatics, such as those sold under the names Solventnaphtha, Solvesso®, Isopar®, Nappar®, Varsol® (ExxonMobil Chemical Central Europe, Cologne, DE) and Shellsol® (Shell Deutschland Oil GmbH, Hamburg, DE), but also solvents such as dimethylfuran, 2-methyltetrahydrofuran, dimethylisosorbide (DMI), γ-valerolactone, propylene glycol diacetate, diethylene glycol dimethyl ether, Dipropylene glycol dimethyl ether, diethylene glycol ethyl and butyl ether acetate, N-methylpyrrolidone and N-methylcaprolactam, or any mixtures of such solvents.

[0066] Following the reaction of polyisocyanate A) with citrate B), when the content of free isocyanate groups is preferably 2% or less by weight, preferably 1% or less by weight, particularly preferably 0.5% or less by weight, and most particularly preferably 0.3% or less by weight, the blocked polyisocyanates can optionally be further diluted with solvents, for example to reduce the viscosity. In addition to the solvents mentioned above, alcoholic solvents such as n-butanol or isobutyl alcohol can also be used, since the isocyanate groups have then reacted largely, preferably completely, with the blocking agent.

[0067] In the process according to the invention, other auxiliaries and additives, such as antioxidants or light stabilizers, may optionally be used. These can be added either to one or more of the reactants A), B) and, if appropriate, to the catalyst before the actual reaction begins. However, they can also be added to the reaction mixture at any time during the reaction or to the blocked polyisocyanates according to the invention after the reaction.

[0068] Suitable antioxidants are, for example, phenols, in particular sterically hindered phenols, such as 2,6-di-tert-butylphenol, 2,4-dimethyl-6-tert-butylphenol, 2,6-di-tert-butyl-4-methylphenol, triethylene glycol bis(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate,

[0069] Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate), esters of 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid with aliphatic branched C7 to C9 alcohols, such asisoheptyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, isooctyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate or isononyl-3-(3,5-di-tert-butyl-4-hydroxyphenylpropionate, Isotridecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, thiodiethyl bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], N,N'-hexamethylene-bis(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid amide, 1 ,2-Bis(3,5-di-tert-butyl-4-hydroxyphenylpropionic acid)hydrazide, 2,4-di-tert-butylphenyl-4'-hydroxy-3',5'-di-tert- butyl benzoate, esters of (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetic acid with aliphatic branched C10 to C14 alcohols, 2,2'-thio-bis(4-methyl-6-tert-butylphenol), 2-methyl-4,6-bis(octylthiomethyl)phenol, 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate or 2,5-di-tert-amylhydroquinone.

[0070] Suitable antioxidants are also thioethers, such as didodecyl-3,3'-thiodipropionate or dioctadecyl-3,3'-thiodipropionate, which are preferably used in combination with phenolic antioxidants of the type mentioned.

[0071] Other suitable antioxidants are phosphites, for example di- or preferably trisubstituted phosphites, such as: B. dibutyl phosphite, dibenzyl phosphite, triethyl phosphite, tributyl phosphite, triisodecyl phosphite, trilauryl phosphite, tris (tridecyl) phosphite, triphenyl phosphite, tris (2,4-di-tert-butylphenyl) phosphite, tris (nonylphenyl) phosphite, diphenyl isooctyl phosphite, Diphenyl isodecyl phosphite, diisodecyl phenyl phosphite, diisooctyl-octylphenyl phosphite, phenyl neopentyl glycol phosphite, 2,4,6-T ri-tert-butylphenyl-(2-butyl-2-ethyl-1,3-propanediol) phosphite, diisodecyl pentaerythritol diphosphite, distearyl pentaerythritol diphosphite, Bis(2,4-di-tert-butylphenyl)-pen-taerythritol diphosphite or tetraphenyl-dipropylene glycol diphosphite.

[0072] Suitable light stabilizers include, for example, UV absorbers of the 2-hydroxyphenylbenzotriazole type, those of the nitrogen-substituted or unsubstituted HALS compound type, such as Tinuvin® 292 or Tinuvin® 770 DF (BASF SE, Ludwigshafen, Germany), or those described, for example, in "Lichtschutzmittel für Lacke" (A. Valet, Vincentz Verlag, Hanover, 1996) and "Stabilization of Polymeric Materials" (H. Zweifel, Springer Verlag, Berlin, 1997, Appendix 3, pp. 181-213).

[0073] Further auxiliaries and additives which may optionally be used in the process according to the invention are also the hydrazide group-containing and / or hydroxy-functional stabilizers described in EP-A 0 829 500, such as, for example, the addition product of hydrazine and propylene carbonate.

[0074] The auxiliaries and additives mentioned can optionally be used in the process according to the invention individually or in any desired combinations with one another in amounts of from 0.001 to 3.0% by weight, preferably from 0.002 to 2.0% by weight, particularly preferably from 0.005 to 1.0% by weight, in each case based on the total amount of polyisocyanate A).

[0075] Irrespective of the type of process, the process according to the invention provides completely clear and transparent polyisocyanates blocked with triesters of citric acid (in the context of the present invention also citrates) or organic solutions of such polyisocyanates, which have a considerably lower toxicity of the blocking agent, a very high storage and solidification stability and low viscosity.

[0076] The invention therefore also relates to the blocked polyisocyanate obtainable or obtained by the process according to the invention.

[0077] The invention further relates to the use of one or more citrates as blocking agents for isocyanate groups or for the preparation of a blocked polyisocyanate. Surprisingly, the citrates can be used for reversible blocking.

[0078] Furthermore, the use of one or more citrates to reduce the viscosity of blocked polyisocyanates and / or to reduce the deblocking temperature of blocked polyisocyanates is a further subject of the present invention. Compared to the products known from the prior art, the blocked polyisocyanates according to the invention have significantly lower viscosities, so that they can be used with a higher solids content. This results in the further advantage of an improved environmental balance. The blocked polyisocyanates according to the invention represent valuable starting materials for the production of polyurethane plastics by the isocyanate polyaddition process. They are outstandingly suitable as crosslinker components for one-component, thermosetting, solvent-based or aqueous coating systems, which are used in particular in plastics coating, automotive original coating, or coil coating applications.

[0079] The invention therefore further provides compositions comprising at least one blocked polyisocyanate according to the invention and at least one compound reactive toward isocyanate groups. The composition according to the invention is preferably a coating agent.

[0080] The invention also relates to a process for producing a shaped body or an adhesive or a coating on a substrate by reacting a blocked polyisocyanate according to the invention with at least one compound reactive towards isocyanate groups, optionally under the action of heat, or by reacting a composition according to the invention, optionally under the action of heat.

[0081] The present invention also further relates to a shaped body or bonded substrate or coated substrate comprising a cured composition according to the invention or comprising a reaction product of a blocked polyisocyanate according to the invention with at least one compound reactive towards isocyanate groups or comprising a product obtainable or produced by the process for producing a shaped body or an adhesive or a coating on a substrate by reacting a blocked polyisocyanate according to the invention with at least one compound reactive towards isocyanate groups, optionally under the action of heat, or by reacting a composition according to the invention, optionally under the action of heat.

[0082] The features and embodiments identified as examples and as preferred for the blocked polyisocyanate according to the invention and the process according to the invention are also preferred for the other subject matters of the invention.

[0083] The following examples serve to illustrate the present invention, but should in no way be construed as limiting the scope of protection. Examples

[0084] Syntheses were carried out inertly, using the Schlenk technique, in previously baked glass apparatus under dry nitrogen.

[0085] Unless otherwise stated, all percentages are based on weight.

[0086] The determination of the NCO contents, including the determination of the contents of free NCO groups, was carried out titrimetrically according to DIN EN ISO 11909:2007-05.

[0087] The course of the blocking reaction and the NCO-free nature of the blocked polyisocyanates were determined by the decrease or absence of the isocyanate band (approx. 2270 cm -1 ) in the IR spectrum.

[0088] The residual monomer contents were measured according to DIN EN ISO 10283:2007-11 using gas chromatography with an internal standard.

[0089] All viscosity measurements were carried out using a Physica MCR 51 rheometer from Anton Paar Germany GmbH (DE) according to DIN EN ISO 3219:1994-10 at a shear rate of 250 s' 1 .

[0090] The platinum-cobalt color number was measured spectrophotometrically according to DIN EN ISO 6271-2:2005-03 using a LICO 400 spectrophotometer from Lange, Germany.

[0091] TGA-FT-IR:

[0092] The thermogravimetric analysis was carried out using a TG 209 F1 Libra® coupled to a Bruker ALPHA II FT-IR spectrometer.

[0093] 10 mg of sample (open alumina crucible) is heated in a nitrogen atmosphere. Heating rate 20 K / min, temperature range 30°C - 1000°C. IR spectra are recorded during the heating of the TGA. A spectrum measurement takes approximately 20 seconds (16 scans are added to form one spectrum), and absorption is measured in the range of 4000 cm². -1 up to 500 cnr 1 , T emperature of the measuring cell and the transfer line 200 °C.

[0094] Chemicals and starting compounds

[0095] Triethyl citrate (Merck KGaA, Sigma Aldrich Germany)

[0096] Tributyl citrate (Merck KGaA, Sigma Aldrich Germany)

[0097] MEKO (Merck KGaA, Sigma Aldrich Germany)

[0098] 8-Caprolactam (Merck KGaA, Sigma Aldrich Germany)

[0099] Hexamethylene diisocyanate HDI (Desmodur® H, Covestro Deutschland AG) Pentamethylene diisocyanate (Covestro Deutschland AG)

[0100] Isophorone diisocyanate, IPDI (Desmodur® I, Covestro Deutschland AG) Desmodur® BL 3175 (MEKO blocked HDI polyisocyanate, Covestro Deutschland AG) Desmodur® BL 4265 (MEKO blocked IPDI polyisocyanate Covestro Deutschland AG) Desmodur® BL 3272 (s-caprolactam blocked HDI polyisocyanate Covestro Deutschland AG) Desmodur® BL 2078 / 2 (s-caprolactam blocked HDI polyisocyanate Covestro Deutschland AG)

[0101] Butyl acetate (Azelis Deutschland GmbH)

[0102] Solvent Naphtha 150 ND (S 150 ND) (DHC Solvent Chemie GmbH)

[0103] Desmorapid® SO (Covestro Deutschland AG)

[0104] Starting polyisocyanates

[0105] Polyisocyanate 1 :

[0106] Polyisocyanate containing isocyanurate groups based on HDI, produced according to EP 330 966.

[0107] 1000 g of hexamethylene diisocyanate (HDI) were placed in a four-necked flask equipped with a stirrer, reflux condenser, N2 flow tube, and internal thermometer. The mixture was degassed three times at room temperature by applying a vacuum of approximately 50 mbar and vented with nitrogen. To initiate the trimerization reaction, 12 g of a catalyst solution, 0.5% (2-hydroxyethyl)trimethylammonium hydroxide, in a Ti mixture of methanol and 2-ethylhexane-1,3-diol, were then added dropwise over a period of 30 minutes and slowly heated to 70°C. The mixture heated to approximately 75°C and was stirred at this temperature for one hour. A further 12 g of catalyst solution were then added dropwise, and the reaction mixture was stirred until an NCO content of 38.0% was reached.The reaction was quenched with equimolar dibutyl phosphate (25% in HDI) (based on catalyst loading) and then freed from excess HDI by thin-film distillation (130 °C, 0.1 mbar). A colorless polyisocyanurate polyisocyanate with the following characteristics was obtained:

[0108] NCO content: 21.7 wt.%

[0109] Content of monomeric HDI: < 0.1%

[0110] Solids content: 100%

[0111] Viscosity (23°C): 3000 mPas Polyisocyanate 2:

[0112] Polyisocyanate containing isocyanurate groups based on PDI, produced according to WO 2017 / 021150.

[0113] 1000 g (6.49 mol) of 1,5-pentamethylene diisocyanate (PDI) were placed in a four-necked flask equipped with a stirrer, reflux condenser, N2 flow tube, and internal thermometer. The mixture was degassed three times at room temperature by applying a vacuum of approximately 50 mbar and vented with nitrogen. The mixture was then heated to 60 °C, and the catalyst solution (1.5% (2-hydroxyethyl)trimethylammonium hydroxide in a 1:1 mixture of methanol and 2-ethylhexane-1,3-diol) was added at a rate such that the temperature of the reaction mixture warmed to a maximum of 80 °C despite the exothermic trimerization reaction. After reaching an NCO content of 36.5 wt.%, the reaction was stopped with dibutyl phosphate (equimolar amount based on the trimethylbenzylammonium hydroxide used) and the unreacted monomeric PDI was separated in a thin-film evaporator at a temperature of 140 °C and a pressure of 0.5 mbar.A practically colorless polyisocyanurate polyisocyanate with the following characteristics was obtained:.

[0114] NCO content: 21.2 wt.%

[0115] Content of monomeric PDI: < 0.1%

[0116] Solids content: 100%

[0117] Viscosity (23°C): 9850 mPas

[0118] Polyisocyanate 3:

[0119] Polyisocyanate containing isocyanurate groups based on I PDI, manufactured according to EP 0 003 765:

[0120] 1332 g (6 mol) of IPDI were placed in a four-necked flask equipped with a stirrer, reflux condenser, N2 flow tube, and internal thermometer. The mixture was degassed three times at room temperature by applying a vacuum of approximately 50 mbar and vented with nitrogen. 10 mL of a catalyst solution of 2-hydroxyethyltrimethylammonium hydroxide (6% dissolved in 2-ethylhexanol / methanol 4:1 v / v) were added dropwise. An exothermic reaction set in within 30 minutes (75 °C max.). The mixture was then heated to 80 °C, and the reaction mixture was stirred until the NCO content of the solution reached 31.1% (approx. 30 min). The excess IPDI was removed by thin-film distillation, and the resulting resin was dissolved in butyl acetate at 70%. A practically colorless polyisocyanurate polyisocyanate with the following characteristics was obtained: NCO content: 11.9 wt.%

[0121] Monomeric IPDI content: 0.2%

[0122] Solids content: 70%

[0123] Viscosity (23°C): 620 mPas (70% in BA)

[0124] Blocked (poly)isocyanates

[0125] Model compound: Blocked isocyanate from triethyl citrate and butyl isocyanate

[0126] Butyl isocyanate (0.46 g, 4.64 mmol, 1.0 eq) was mixed with Desmorapid® SO (200 ppm). Triethyl citrate (1.28 g, 4.64 mmol, 1.0 eq) was added dropwise to this mixture under dry nitrogen and with mechanical stirring. The reaction mixture was then heated to 50°C and stirred until all NCO groups had reacted (determined by IR spectroscopy). A colorless, blocked isocyanate was obtained. Complete blocking was further confirmed by 13 C{ 1 H}-NMR spectroscopy confirmed characteristic urethane signal at 154.3 ppm and missing signal of the carbon atom of the isocyanate group of butyl isocyanate at 122.1 ppm.

[0127] The resulting product was then treated with n-butanol (4 mL) and stirred for 3 h at 120°C. After cooling, the solution was again 13 C{ 1 H}-NMR spectroscopy. The characteristic signal of the urethane bond formed by triethyl citrate and butyl isocyanate at 154.3 ppm is absent; instead, a new urethane species is observed at 156.9 ppm, which can be assigned to the urethane bond formed by butyl isocyanate and n-butanol. Free triethyl citrate is also present in the reaction mixture.

[0128] The prepared model substance was further subjected to thermogravimetric analysis coupled with FT-IR spectroscopy. It was shown that free isocyanate ( = 2270 cm -1 ) is formed.

[0129] The above-mentioned studies demonstrate the successful use of citrates as blocking agents for isocyanates.

[0130] Example 1 (according to the invention):

[0131] Polyisocyanate 1 (157.50 g, 1.0 eq) was dissolved in butyl acetate (68 g) and mixed with Desmorapid® SO (200 ppm). Triethyl citrate (226.3 g, 0.82 mol, 1.0 eq) was added dropwise to this solution under dry nitrogen and with mechanical stirring. The reaction mixture was then heated to 50°C and stirred until all NCO groups had reacted (determined by IR spectroscopy). A colorless, blocked polyisocyanate with the following characteristics was obtained:

[0132] Free NCO content: 0.0%

[0133] Blocked NCO content: 6.7%

[0134] Solids content: 75%

[0135] Viscosity (23°C): 1500 mPas

[0136] Example 2 (according to the invention):

[0137] Polyisocyanate 1 (98.25 g, 1.0 eq) was dissolved in butyl acetate (42.1 g) and mixed with Desmorapid® SO (200 ppm). Tributyl citrate (184.4 g, 0.51 mol, 1.0 eq) was added dropwise to this solution under dry nitrogen and with mechanical stirring. The reaction mixture was then heated to 50°C and stirred until all NCO groups had reacted (determined by IR spectroscopy). A colorless, blocked polyisocyanate with the following characteristics was obtained:

[0138] Free NCO content: 0.0%

[0139] Blocked NCO content: 5.7%

[0140] Solids content: 75%

[0141] Viscosity (23°C): 500 mPas

[0142] Example 3 (according to the invention):

[0143] Polyisocyanate 2 (140.0 g, 1.0 eq) was dissolved in butyl acetate (115.0 g) and mixed with Desmorapid® SO (200 ppm). Triethyl citrate (202.0 g, 0.73 mol, 1.0 eq) was added dropwise to this solution under dry nitrogen and with mechanical stirring. The reaction mixture was then heated to 50°C and stirred until all NCO groups had reacted (determined by IR spectroscopy). A colorless, blocked polyisocyanate with the following characteristics was obtained:

[0144] Free NCO content: 0.0%

[0145] Blocked NCO content: 6.7%

[0146] Solids content: 75%

[0147] Viscosity (23°C): 3650 mPas Example 4 (according to the invention)

[0148] Polyisocyanate 3 (140.0 g, 1.0 eq) was dissolved in butyl acetate (160.0 g) and mixed with Desmorapid® SO (200 ppm). Triethyl citrate (159.0 g, 0.51 mol, 1 eq) was added dropwise to this solution under dry nitrogen and with mechanical stirring. The reaction mixture was then heated to 50°C and stirred until all NCO groups had reacted (determined by IR spectroscopy). A colorless, blocked polyisocyanate with the following characteristics was obtained:

[0149] Free NCO content: 0.0%

[0150] Blocked NCO content: 5.2%

[0151] Solids content: 65%

[0152] Viscosity (23°C): 640 mPas

[0153] Comparison example 1 (not according to the invention):

[0154] Desmodur® BL 3175, a MEKO blocked HDI polyisocyanate

[0155] Blocked NCO content: 11.1%

[0156] Solids content: 75%

[0157] Viscosity (23°C): 3300 mPas

[0158] Comparison example 2 (not according to the invention):

[0159] Desmodur® BL 4265, a MEKO blocked IPDI polyisocyanate

[0160] Blocked NCO content: 8.1%

[0161] Solids content: 65%

[0162] Viscosity (23°C): 11000 mPas

[0163] Comparative Example 3 (MEKO blocked PDI polyisocyanate, not according to the invention):

[0164] Polyisocyanate 2 (173 g, 1 eq) was mixed with butyl acetate (83.3 g) under dry nitrogen and with mechanical stirring. The mixture was heated to 50 °C, and MEKO (77 g, 1 eq) was slowly added dropwise, during which the internal temperature rose to 70 °C. The mixture was stirred at 70 °C until all NCO groups had reacted (IR control). A colorless, blocked polyisocyanate with the following characteristics was obtained:

[0165] Blocked NCO content: 11.1% Solids content: 75%

[0166] Viscosity (23°C): 4300 mPas

[0167] Comparative Example 4 (not according to the invention):

[0168] Desmodur® BL3272, an s-caprolactam blocked HDI polyisocyanate

[0169] Blocked NCO content: 10.2%

[0170] Solids content: 72%

[0171] Viscosity (23°C): 2700 mPas

[0172] Comparative Example 5 (not according to the invention):

[0173] Desmodur® BL2078 / 2, an s-caprolactam blocked IPDI polyisocyanate

[0174] Blocked NCO content: 7.0%

[0175] Solid content: 60%

[0176] Viscosity (23°C): 1750 mPas

[0177] Table 1 : Comparison of viscosities of the different blocked polyisocyanates.

[0178] Out of

[0179] Table 1 shows that Examples 1, 2 and 3 according to the invention give products with significantly lower viscosity than comparable blocked polyisocyanates (Comparative Examples 1-4). This is the case both at the same and at a higher solids content. An examination of the viscosities of the series of blocked HDI polyisocyanates (Comparative Example 1, Examples 1 and 2) impressively shows that the system blocked with tributyl citrate, Example 2, has an even lower viscosity than Example 1 or Comparative Example 1. Blocked polyisocyanates based on pentamethylene diisocyanate have significantly higher viscosities than the corresponding HDI types, cf. Comparative Example 1 and Comparative Example 3. The viscosity of the PDI polyisocyanate blocked with triethyl citrate according to the invention from Example 3 is significantly lower than the corresponding MEKO blocked variant.From Example 4, in comparison with Comparative Examples 2 and 5, it is clear that this also applies to the IPDI-based polyisocyanates.

Claims

1. Blocked polyisocyanate containing two or more 2-carbamoylpropane-1,2,3-tricarboxylate structures.

2. Blocked polyisocyanate according to claim 1, characterized in that it additionally contains one or more isocyanurate, allophanate, urethane, urea, uretdione, iminooxadiazinedione, oxadiazinetrione and / or biuret structures.

3. Blocked polyisocyanate according to one of claims 1 or 2, characterized in that the two or more 2-carbamoylpropane-1,2,3-tricarboxylate structures have a general formula (I), have in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 18 carbon atoms, saturated or unsaturated cycloaliphatic radical having 3 to 18 carbon atoms, araliphatic radical having 7 to 18 carbon atoms and / or aromatic radical having 6 to 18 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain.

4. Blocked polyisocyanate according to one of claims 1 to 3, characterized in that the two or more 2-carbamoylpropane-1,2,3-tricarboxylate structures have a general formula (I), (I) in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 8 carbon atoms and / or saturated or unsaturated cycloaliphatic radical having 5 to 8 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain, preferably in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 4 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain, particularly preferred in which R independently represents any saturated or unsaturated, linear or branched, aliphatic radical having 2 to 4 carbon atoms.

5. A process for preparing a blocked polyisocyanate according to any one of claims 1 to 4, comprising reacting at least one polyisocyanate A) with at least one citrate B), optionally in the presence of at least one catalyst, wherein the citrate B) is used in an amount of > 95 equivalent% based on the isocyanate groups of the polyisocyanate A).

6. Method according to claim 5, characterized in that the at least one Polyisocyanate A) has aliphatically, cycloaliphatically, araliphatically and / or aromatically bound isocyanate groups and / or preferably one or more isocyanurate structures containing polyisocyanates based on 1,5-diisocyanatopentane, 1,6-diisocyanatohexane, 1-isocyanato-3,3,5-trimethyl-5-isocyanatomethylcyclohexane, 1,3-bis(isocyanatomethyl)benzene, bis- (isocyanatomethyl)norbornane and / or 4,4'-diisocyanatodicyclohexylmethane.

7. Process according to claim 5 or 6, characterized in that the at least one citrate B) is one of the general formula (II), (II) is in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 18 carbon atoms, saturated or unsaturated cycloaliphatic radical having 3 to 18 carbon atoms, araliphatic radical having 7 to 18 carbon atoms and / or aromatic radical having 6 to 18 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain.

8. Process according to one of claims 5 to 7, characterized in that the at least one citrate B) is one of the general formula (II), (II) is in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 8 carbon atoms and / or saturated or unsaturated cycloaliphatic radical having 5 to 8 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain, preferably in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 1 to 4 carbon atoms, each of which is substituted or unsubstituted and / or has heteroatoms in the chain, particularly preferably in which R independently of one another represents any saturated or unsaturated, linear or branched, aliphatic radical having 2 to 4 carbon atoms.

9. The process according to any one of claims 5 to 8, characterized in that the at least one catalyst is present in amounts of 1 to 10,000 ppm, preferably 10 to 5,000 ppm, particularly preferably 10 to 1,000 ppm and very particularly preferably 10 to 250 ppm.

10. Composition comprising at least one blocked polyisocyanate according to any one of claims 1 to 4 and at least one compound reactive towards isocyanate groups.

11. A process for producing a shaped body or an adhesive or a coating on a substrate by reacting a blocked polyisocyanate according to any one of claims 1 to 4 with at least one compound reactive towards isocyanate groups, optionally with the action of heat, or by reacting a composition according to claim 10, optionally with the action of heat.

12. A molded article or bonded substrate or coated substrate comprising a cured composition according to claim 10 or comprising a reaction product of a blocked polyisocyanate according to any one of claims 1 to 4 with at least one compound reactive toward isocyanate groups or comprising a product obtainable or produced by the process according to claim 11.

Images